SEARCH

SEARCH BY CITATION

References

  • 1
    Kelly DA. Current results of evolving indications for liver transplantation in children. J Pediatr Gastroenterol Nutr 1998; 27: 214221.
  • 2
    Busuttil R, Seu P, Millis J. Liver transplantation in children. Ann Surg 1991; 213: 4857.
  • 3
    Burdelski M, Rogiers X. Liver transplantation in metabolic disorders. Acta Gastroenterol 1999; 62: 300305.
  • 4
    Pratschke J, Steinmuller T, Bechstein WO et al. Orthotopic liver transplantation for hepatic associated metabolic disorders. Clin Transplant 1998; 12: 228232.
  • 5
    Grewal HP, Brady L, Cronin IIDC et al. Combined liver and kidney transplantation in children. Transplantation 2000; 70: 100105.
  • 6
    Peeters PM, Sieders E, De Jong KP et al. Comparison of outcome after pediatric liver transplantation for metabolic diseases and biliary atresia. Eur J Pediatr Surg 2001; 11: 2835.
  • 7
    Kayler LK, Merion RM, Lee S et al. Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant 2002; 6: 295–300.
  • 8
    Opelz G, Pfarr E, Engelmann A, Keppel E, for the Collaborative Transplant Study. Kidney graft survival rates in black cyclosporinetreated recipients. Transplant Proc 1989; 21: 39183920.
  • 9
    Takemoto S, Terasaki PI, Cecka JM, Cho YW, Gjertson DW. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. N Engl J Med 1992; 327: 834839.
  • 10
    Koyama H, Cecka JM, Terasaki PI. Kidney transplants in black recipients. HLA matching and other factors affecting long-term graft survival. Transplantation 1994; 57: 10641068.
  • 11
    Gonwa TA, Morris CA, Mai ML, Husberg BS, Goldstein RM, Goran BK. Race and liver transplantation. Arch Surg 1991; 126: 11411143.
  • 12
    Russo MW, Sandler RS, Mandelkehr L, Fair JH, Johnson MW, Brown RS. Payer status, but not race, affects the cost of liver transplantation. Liver Transpl Surg 1998; 4: 370377.
  • 13
    Eckhoff DE, McGuire BM, Young C et al. Race. A critical factor in organ donation, patient referral and selection, and orthotopic liver transplantation. Liver Transpl Surg 1998; 4: 499505.
  • 14
    Pillay P, Van Thiel DH, Gavaler JS, Starzl TE. Effect of race upon organ donation and recipient survival in liver transplantation. Dig Dis Sci 1990; 35: 13911396.
  • 15
    Teperman L, Scantlebury V, Staschak A, Todo S, Starzl TE. Liver transplantation in black recipients: Pittsburgh. Transplant Proc 1989; 21: 39633965.
  • 16
    Gupta P, Hart J, Cronin D, Kelly S, Millis JM, Brady L. Risk factors for chronic rejection after pediatric liver transplantation. Transplantation 2001; 72: 10981102.
  • 17
    Delvin JJ, O'Grady JG, Tan KC, Calne RY, Williams R. Ethnic variations in patient and graft survival after liver transplantation. Transplantation 1993; 56: 13811384.
  • 18
    Nair S, Thuluvath PJ. Does race-matched liver transplantation offer any graft survival benefit? Trans Proc 2001; 33: 15231524.
  • 19
    Seaberg EC, Belle SH, Beringer KC, Schivins JL, Detre KM. Long-term patient and retransplantation-free survival by selected recipient and donor characteristics: an update from the Pitt-UNOS Liver Transplant Registry. In: CeckaJM, TerasakiPI, eds. Clinical Transplants 1997. Los Angeles: UCLA Tissue Typing Laboratory; 1998. pp 1528.
  • 20
    Brown RS, Lombardero M, Lake JR. Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation. Transplantation 1996; 62: 17881793.
  • 21
    Jamieson NV. The results of combined liver/kidney transplantation for primary hyperoxaluria (PH1) 1984–97. The European PH1 transplant registry report. J Nephrol 1998; 11: 3641.
  • 22
    Whitington PF, Alonso EM, Piper J. Pediatric liver transplantation. Sem Liver Dis 1994; 14: 303317.
  • 23
    Matern D, Starzl TE, Arnaout W et al. Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr 1999; 158: S43S48.
  • 24
    Revell SP, Noble-Jamieson G, Johnston P, Rasmussen A, Jamieson N, Barnes ND. Liver transplantation for homozygous familial hypercholesterolaemia. Arch Dis Child 1995; 73: 456458.
  • 25
    Whitington PF, Alonso EM, Boyle JT et al. Liver transplantation for the treatment of urea cycle disorders. J Inherit Metab Dis 1998; 21 (Suppl. 1): 112118.
  • 26
    Van't Hoff W, McKiernan P, Surtees R, Leonard J. Liver transplantation for methylmalonic acidaemia. Eur J Pediatr 1999; 158 (Suppl. 2): S70S74.
  • 27
    Schlenzig JS, Poggi-Travert F, Laurent J et al. Liver transplantation in two cases of propionic acidaemia. J Inher Metab Dis 1995; 18: 448461.
  • 28
    Peeters PM, Sieders E, Ten-Vergert EM et al. Analysis of growth in children after orthotopic liver transplantation. Transpl Int 1996; 9: 581588.
  • 29
    Van Der Veere CN, Sinaasappel M, McDonagh AF et al. Current therapy for Crigler–Najjar Syndrome type 1. Report of a world registry. Hepatology 1996; 24: 311315.
  • 30
    Bilheimer DW, Goldstein JL, Grundy SM, Starzl TE, Brown MS. Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med 1984; 311: 16581664.
  • 31
    Msall M, Batshaw M, Suss R. Neurologic outcome in children with inborn errors of urea synthesis. N Engl J Med 1984; 310: 15001505.
  • 32
    Fletcher J, Couper R, Moore D, Coxon R, Dorney S. Liver transplantation for citrullinemia improves intellectual function. J Inher Metab Dis 1999; 22: 581586.
  • 33
    Matsui SM, Mahoney MJ, Rosenberg LE. The natural history of the inherited methylmalonic acidemias. N Engl J Med 1983; 308: 857861.
  • 34
    Cochat P, Gaulier JM, Koch Nogueira PC et al. Combined liver-kidney transplantation in primary hyperoxaluria type 1. Eur J Pediatr 1999; 158 (Suppl. 2): S75S80.